Trials / Conditions / 22q11 Deletion Syndrome
22q11 Deletion Syndrome
7 registered clinical trials studyying 22q11 Deletion Syndrome — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorde NCT06081348 | Holland Bloorview Kids Rehabilitation Hospital | Phase 2 |
| Completed | Mindfulness Program for Adolescents With 22q11DS NCT05849441 | Innovation Research & Training | N/A |
| Recruiting | Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome NCT05664412 | Stephan Eliez | N/A |
| Completed | NB-001 in Children and Adolescents With 22q11 Deletion Syndrome NCT05290493 | Nobias Therapeutics, Inc. | Phase 2 |
| Recruiting | GROWing Up With Rare GENEtic Syndromes NCT04463316 | dr. Laura C. G. de Graaff-Herder | — |
| Completed | SNP-based Microdeletion and Aneuploidy RegisTry (SMART) NCT02381457 | Natera, Inc. | — |
| Unknown | Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion NCT02070211 | Bambino Gesù Hospital and Research Institute | Phase 2 / Phase 3 |